1. 2023
  2. Development of experimental mouse xenograft models of human tumors for preclinical in vivo studies of product for cellular immunotherapy

    Lopatnikova, J. A., Shevchenko, J. A., Filippova, J. G., Fisher, M. S., Obleukhova, I. A., Zavjalov, E. L., Solovjeva, O. I., Razumov, I. A., Akahori, Y., Shiku, H. & Sennikov, S. V., 2023, In: Immunologiya. 44, 6, p. 709-720 12 p.

    Research output: Contribution to journalArticlepeer-review

  3. Investigation of TNF receptor coexpression parameters as potential biomarkers of effective hospital therapy with rituximab in patients with rheumatoid arthritis

    Alshevskaya, A. A., Lopatnikova, J. A., Zhukova, J. V., Kireev, F. D., Gladkikh, V. S., Shkaruba, N. S., Chumasova, O. A., Sizikov, A. E. & Sennikov, S. V., 2023, In: Immunologiya. 44, 4, p. 429-443 15 p.

    Research output: Contribution to journalArticlepeer-review

  4. 2022
  5. The Role of Tumor-Associated Antigen HER2/neu in Tumor Development and the Different Approaches for Using It in Treatment: Many Choices and Future Directions

    Alrhmoun, S. & Sennikov, S., 14 Dec 2022, In: Cancers. 14, 24, 6173.

    Research output: Contribution to journalReview articlepeer-review

  6. In Vitro Model of Suppression of the Alloantigen Response by Tolerogenic Dendritic Cells Transfected with Personalized DNA Constructs Encoding HLA Epitopes

    Shevchenko, J. A., Lopatnikova, J. A., Khantakova, J. N., Silkov, A. N., Kuznetsova, M. S., Kurilin, V. V., Maksyutov, A. Z. & Sennikov, S. V., Jun 2022, In: Frontiers in Bioscience - Landmark. 27, 6, 170.

    Research output: Contribution to journalArticlepeer-review

  7. Современная терапия рака молочной железы: от тамоксифена до т-клеточной инженерии

    Shevchenko, J. A., Kuznetsova, M. S., Khristin, A. A., Sidorov, S. V. & Sennikov, S. V., 2022, In: Siberian Journal of Oncology. 21, 5, p. 109-122 14 p., 12.

    Research output: Contribution to journalArticlepeer-review

  8. 2021
  9. Ligand-regulated expression of TNF receptors 1 and 2 determines receptor-mediated functional responses

    Alshevskaya, A., Koneva, O., Belomestnova, I., Lopatnikova, J., Evsegneeva, I., Zhukova, J., Kireev, F., Karaulov, A. & Sennikov, S., 1 Nov 2021, In: International Archives of Allergy and Immunology. 182, 11, p. 1077-1088 12 p.

    Research output: Contribution to journalArticlepeer-review

  10. Short-term rituximab and methylprednisolone therapy led to restoration of TNFR1 density level on TNFR1+TNFR2+double-positive T cells in rheumatoid arthritis reflecting the effectiveness of treatment

    Alshevskaya, A., Lopatnikova, J., Zhukova, J., Chumasova, O., Shkaruba, N., Sizikov, A. & Sennikov, S., Aug 2021, In: European Journal of Immunology. 51, p. 232-232 1 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  11. Number and co-expression of TNF receptors type 1 and 2 on immunocompetent cells are associated with stability of remission in rheumatoid arthritis patients

    Alshevskaya, A., Lopatnikova, J., Zhukova, J., Chumasova, O., Shkaruba, N., Sizikov, A. & Sennikov, S., Jun 2021, In: Annals of the rheumatic diseases. 80, Suppl 1, p. 482-483 3 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  12. The murine DCs transfected with DNA-plasmid encoding CCR9 demonstrate the increased migration to CCL25 and thymic cells in vitro and to the thymus in vivo

    Tereshchenko, V., Bulygin, A., Zavodskii, R., Maksyutov, A., Kurilin, V., Fisher, M., Semenyuk, N., Aladev, S. & Sennikov, S., Jun 2021, In: Cytokine. 142, 155473.

    Research output: Contribution to journalArticlepeer-review

  13. Особенности количественной экспрессии рецепторов checkpoint-молекул PD-1 и TIM-3 на CD4+ и CD8+Т-клетках при раке молочной железы разной степени прогрессии

    Shevchenko, Y. A., Kuznetsova, M. S., Khantakova, Y. N., Obleukhova, I. A., Khristin, A. A., Sidorov, S. V. & Sennikov, S. V., 2021, In: Medical Immunology (Russia). 23, 4, p. 865-870 6 p., 38.

    Research output: Contribution to journalArticlepeer-review

ID: 16345732